• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Olympus makes trio of executive changes including at CFO

Olympus makes trio of executive changes including at CFO

April 1, 2026 By Sean Whooley

Olympus newly appointed executive officers Michael Parenti Simone Berger David Shan photoshop
[Image from Olympus on LinkedIn]
Olympus today announced a series of changes within its executive leadership team, including the chief financial officer role.

The company also made changes at chief human resources officer (CHRO) and chief manufacturing and supply officer (CMSO).

Olympus named Michael Parenti as its new CFO, with Simone Berger named CHRO and David Shan picked as CMSO. These appointments follow the naming of Denise Lane to the role of chief officer of inclusion (COI) last month. All appointments, including Lane, went into effect today, April 1, 2026.

Olympus continues to execute on a new corporate strategy introduced in late 2025. President and CEO Bob White explained his plans for the future of Olympus to MassDevice in October 2025.

“Michael, Simone, and David bring deep global expertise across financial stewardship, HR transformation, and manufacturing & supply chain optimization,” Olympus said in a LinkedIn post. “Their combined experience will help drive our strategy to strengthen enterprise-wide operations, accelerate performance, and support sustainable growth as a global MedTech leader. We’re excited to see how these leaders will elevate Olympus’ next phase of globalization.”

More on new Olympus CFO Michael Parenti

Olympus attributed the reason for change to seeking to further strengthen its management structure through a succession plan. Parenti succeeds Tatsuya Izumi.

Parenti offers experience across a broad range of finance functions at global medtech and healthcare companies. Olympus said he previously served as CFO in Japan and China in past roles. He previously spent about two decades across several positions at Johnson & Johnson. Most recently, Parenti served as VP and group CFO for MedSurg and Neurotech at Stryker.

“Leveraging his global perspective and proven leadership, Michael is expected to further enhance the company’s financial management capabilities, support disciplined capital allocation, and contribute to sustainable growth and value creation as a Japan-originated global medtech company,” Olympus said.

More on new CHRO Simone Berger

Berger succeeds Shigeto Otsuki, who joined Olympus in 2019 and elected to step down. The company said Otsuki’s contributions to the company focused on HR and general affairs, plus regional and global management responsibilities. Otsuki implemented a globally aligned, job-based HR system and performance management frameworks.

According to Olympus, Berger has extensive global experience across Germany, Singapore and China. She led major culture and people transformation initiatives across industries, the company said.

Berger most recently served as chief people officer at STADA Arzneimittel, a German pharmaceutical company.

“We are now entering the next phase — integrating HR information and processes globally, developing a winning talent strategy, and advancing the Olympus cultural transformation,” Olympus said. “Simone drives HR as a business function with a clear focus on value creation and ROI. Her execution focused enterprise leadership will accelerate these efforts, foster innovation, and deliver new value to our business.”

More on new CMSO David Shan

Shan succeeds Tetsuo Kobayashi, who expressed his intention to step down. Kobayashi led led the reorganization of manufacturing bases and the optimization of the supply chain, contributing to the advancement of quality control and the enhancement of cost competitiveness.

With more than 30 years of experience, Shan’s track record spans manufacturing and supply chain as well as R&D, engineering and quality. He previously successfully drove standardization, automation and transformation of operations on a global scale over his career.

Shan has spent more than a decade in supply chain functions at BD, culminating in his most recent role of EVP and chief integrated supply chain officer, which he took on in 2023. He previously spent time at 3M, as well as other pharmaceutical and packaging companies.

“Leveraging his exceptional leadership and a strong academic and professional background cultivated across multiple countries and regions, we expect him to lead the establishment of a streamlined organizational structure and operating model — transitioning from a region-centric approach to a business-centric one,” Olympus said. “His ability to align diverse teams, optimize processes, and drive efficiencies will be instrumental in strengthening our global operations and enabling sustainable, long-term growth.”

Filed Under: Business/Financial News, Endoscopic, Health Technology, Imaging Tagged With: Olympus, Personnel Moves

More recent news

  • Carlsmed names chief product and AI officer as it claims CMS reimbursements
  • Integra LifeSciences says Cincinnati plant flooding will cost millions
  • Mendaera rolls out handheld needle robot paired with Butterfly ultrasound probe
  • Edwards earns FDA approval for first-of-its-kind size-adjustable pediatric heart valve
  • Leading medical device experts and MDO launch Medtech Innovation Board

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy